BiomeNrich™ PRO G814 & PRO G952: Globally Recognized Bifidobacterium Solutions Now Targeting Southeast Asia's Wellness Market

July 09, 2025 09:00 AM AEST | By Cision
 BiomeNrich™ PRO G814 & PRO G952: Globally Recognized Bifidobacterium Solutions Now Targeting Southeast Asia's Wellness Market
Image source: Kalkine Media

SEOUL, South Korea, July 9, 2025 /PRNewswire/ -- As Southeast Asia's health and wellness market rapidly evolves, consumer expectations are shifting toward multifunctional solutions that go beyond basic digestion. Gut health is now understood as the foundation for immune support, skin clarity, mental balance, and even healthy aging. Among the key microbiome species for gut health, Bifidobacterium bifidum and B. animalis subsp. lactis have emerged as central players in this transformation.

BiomeNrich PRO G814, PRO G952
BiomeNrich PRO G814, PRO G952

Recognizing this growing need for targeted probiotic innovation, CJ BIO has introduced two new Bifidobacterium strains under its advanced BiomeNrich™ PRO G814 (Bifidobacterium bifidum) and PRO G952 (B. animalis subsp. lactis).

Unveiled at Vitafoods Europe 2025, these two human-origin strains reflect CJ BIO's strategy to provide diverse solutions for customers seeking innovative probiotic ingredients for gut health. Their introduction brings new scientific diversity and formulation potential to Southeast Asian partners seeking to meet the region's growing demand for premium gut health ingredients.

The inclusion of Bifidobacterium introduces new clinical potential — especially in targeting life stage –specific microbiome challenges such as age-related declines in Bifidobacterium levels, which are associated with gastrointestinal discomfort.

BiomeNrich™ PRO G814 and PRO G952 are rooted in over 30 years of scientific research, supported by clinical trials and historical use. The safety of the products has been recognized by the U.S. FDA through GRAS (Generally Recognized as Safe) and NDIN (New Dietary Ingredient Notification), as well as being listed in the QPS (Qualified Presumption of Safety) in Europe. Additionally, their usability is supported by certifications, including Halal and Kosher status, catering to religious needs in the Southeast Asian market. These additional measures have been taken to ensure seamless integration into a wide range of finished products for dietary supplements and functional foods.

Beyond safety and regulatory readiness, these strains offer unique advantages in formulation and health outcomes. What sets them apart is not only their clinical performance, but also their origin and quality control. Both strains are isolated from healthy, breastfed infants and selected for their ability to:

  • Strongly adhere to human intestinal epithelial cells
  • Survive in high-acid and bile conditions
  • Deliver measurable benefits for digestive and immune functions

BiomeNrich™ reflects our commitment to holistic, gut-organ axis innovation — with these new Bifidobacterium strains representing our next step in enabling partners to formulate with purpose and precision.

For more details on clinical performance, origin, application formats, and formulation compatibility:
https://online.cjbio.net/bnr_bifido_pr

About CJ BIO Taste & Nutrition Business
CJ BIO is a business unit of CJ CheilJedang, part of CJ Group—an international company founded in South Korea in 1953 with businesses across Food & Food Service, Bio & Pharma, Entertainment & Media, and Retail & Logistics.

CJ BIO is a global leader in fermentation-based bio-products, offering science-driven solutions such as BiomeNrich™ and AMINATURE® for nutrition and wellness. Leveraging its global manufacturing network and microbial fermentation expertise, CJ BIO also provides clean-label taste solutions like TasteNrich® to support innovation in the food and nutrition industries.

CONTACT: Soohyun Paik ([email protected]) +82-2-6740-1209


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.